VEXTF (Vext Science) ROCE %: 0.88% (As of Mar. 2026)


VEXTF Vext Science Inc VEXTF
71 GF Score
Price $0.16
GF Value $1.08
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Vext Science ROCE %?

Vext Science VEXTF 71 ROCE % is 0.88% as of Mar. 2026. GuruFocus rates VEXTF with a GF Score™ of 71/100 and a GF Value™ of $1.08 (Possible Value Trap). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Vext Science's annualized ROCE % for the quarter that ended in Mar. 2026 was 0.88%.

Vext Science  (OTCPK:VEXTF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Vext Science ROCE % Related Terms

Vext Science ROCE % Historical Data

* Premium members only.

The historical data trend for Vext Science's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vext Science ROCE % Chart

Vext Science Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only 15.01 9.79 6.03 -13.77 -10.29

Vext Science Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.06 4.18 -7.61 -27.66 0.88
VEXTF
71GF Score
Vext Science Inc VEXTF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vext Science ROCE % Calculation

Vext Science's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-10.736/( ( (136.967 - 20.276) + (120.529 - 28.494) )/ 2 )
=-10.736/( (116.691+92.035)/ 2 )
=-10.736/104.363
=-10.29 %

Vext Science's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=0.8/( ( (120.529 - 28.494) + (117.179 - 27.325) )/ 2 )
=0.8/( ( 92.035 + 89.854 )/ 2 )
=0.8/90.9445
=0.88 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 0.88% mean?
Vext Science (VEXTF) has a ROCE % of 0.88% as of Mar. 2026.
Is Vext Science's ROCE % too high?
Vext Science's current ROCE % is 0.88%. The Drug Manufacturers industry median ROCE % is 7.03. Vext Science's value of 0.88% is 87.5% below this industry median. Overall, Vext Science has a GF Score™ of 71/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Vext Science's ROCE % compare to ZTS and UTHR?
Vext Science's ROCE % of 0.88% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.03. Vext Science's value of 0.88% is 87.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.03, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vext Science's current ROCE % of 0.88% is 87.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vext Science's current ROCE % is 0.88%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vext Science stock overvalued right now?
Based on GuruFocus' analysis, Vext Science (VEXTF) is currently considered Possible Value Trap. The stock's GF Value™ is $1.08, compared to a current price of $0.16 — trading 84.9% below its estimated fair value. The current ROCE % is 0.88% and 87.5% below the Drug Manufacturers industry median of 7.03. Vext Science's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Vext Science (VEXTF), the current ROCE % is 0.88% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vext Science (VEXTF) Overvalued in 2026?

Based on GuruFocus' analysis, Vext Science stock appears to be undervalued. The current stock price of $0.16 is trading 84.9% below its estimated GF Value™ of $1.08. GuruFocus considers Vext Science to be Possible Value Trap.

Key valuation signals for VEXTF:

  • ROCE %: 0.88%
  • GF Value™: $1.08 vs. price of $0.16 (84.9% below fair value)
  • GF Score™: 71/100 with 3 warning signs
  • Industry Position: 87.5% below the Drug Manufacturers median

No single metric tells the full story. See the VEXTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vext Science Business Description

Other Exchanges VEXT:Canada
Address 4152 N. 39th Avenue, Admin, Phoenix, AZ, USA, 85019
Vext Science Inc engages in the full spectrum of the cannabis product lifecycle, from development and manufacturing to distribution. Its brands include Herbal Wellness, Appalachian Pharm, Revibe, Prism, Vapen, and Firebrand. In Arizona and Ohio, the dispensaries operate under the Herbal Wellness Center brand, while in Ohio the cultivation and manufacturing operations are licensed and branded as Appalachian Pharms Cultivation and Appalachian Pharm Processing. The Company operates through a single operating segment engaged in the cultivation, manufacturing, distribution, and sale of cannabis within the United States. All revenues are generated in the United States.
71GF Score

Get the complete analysis for VEXTF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.16
Price
$1.08
GF Value